Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N-methyl-D-aspartate receptor channels in cultured rat hippocampal neurons

J Neurosci Res. 2005 May 15;80(4):491-500. doi: 10.1002/jnr.20497.

Abstract

In rat hippocampal neurons cultured with the antagonist for N-methyl-D-aspartate (NMDA) receptors dizocilpine (MK-801) for 8 days in vitro (DIV), a significant decrease was seen in the expression of microtubule-associated protein-2 (MAP-2) as well as mRNA for both brain-derived neurotrophic factor (BDNF) and growth-associated protein-43 (GAP-43), in addition to decreased viability. MK-801 not only decreased the expression of the NR1 subunit of NMDA receptors but also increased NR2A expression, without affecting NR2B expression. Repetitive daily exposure to static magnetic fields at 100 mT for 15 min led to a decrease in the expression of MAP-2, without significantly affecting cell viability or the expression of neuronal nuclei (NeuN) and GAP-43. However, the repetitive magnetism prevented decreases in both BDNF mRNA and MAP-2 and additionally increased the expression of NR2A subunit, without altering NR1 expression in neurons cultured in the presence of MK-801. Repetitive magnetism was also effective in preventing the decrease by MK-801 in the ability of NMDA to increase intracellular free Ca2+ ions, without affecting the decrease in the maximal response. These results suggest that repetitive magnetism may at least in part counteract the neurotoxicity of MK-801 through modulation of the expression of particular NMDA receptor subunits in cultured rat hippocampal neurons.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Blotting, Western / methods
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism
  • Calcium / metabolism
  • Cell Survival / drug effects
  • Cell Survival / radiation effects
  • Cells, Cultured
  • Dizocilpine Maleate / pharmacology*
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Extracellular Space / radiation effects
  • GAP-43 Protein / genetics
  • GAP-43 Protein / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Gene Expression Regulation / radiation effects
  • Hippocampus / cytology*
  • Magnetics*
  • Microtubule-Associated Proteins / genetics
  • Microtubule-Associated Proteins / metabolism
  • N-Methylaspartate / pharmacology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / radiation effects*
  • Phosphopyruvate Hydratase / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Time Factors

Substances

  • Brain-Derived Neurotrophic Factor
  • Excitatory Amino Acid Antagonists
  • GAP-43 Protein
  • Microtubule-Associated Proteins
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • Dizocilpine Maleate
  • Phosphopyruvate Hydratase
  • Calcium
  • N-methyl D-aspartate receptor subtype 2A